Logo image of IMUX

IMMUNIC INC (IMUX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:IMUX - US4525EP1011 - Common Stock

0.6646 USD
-0.02 (-3.44%)
Last: 12/5/2025, 8:00:01 PM
0.6803 USD
+0.02 (+2.36%)
After Hours: 12/5/2025, 8:00:01 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
IMUX revenue by date.IMUX revenue by date.
N/AN/AN/AN/A
1,403.93%
N/A
148.01%
N/A
70.84%
N/A
48.49%
N/A
35.86%
EBITDA
YoY % growth
IMUX ebitda by date.IMUX ebitda by date.
-49.25M-50.79M
-3.13%
-39.46M
22.31%
-51.66M
-30.92%
-37.68M
27.06%
-36.98M
1.86%
-48.93M
-32.31%
-74.33M
-51.91%
-86.44M
-16.29%
-99.112M
-14.66%
-97.918M
1.20%
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IMUX ebit by date.IMUX ebit by date.
-50.34M-52.12M
-3.54%
-41.27M
20.82%
-52.66M
-27.60%
-38.41M
27.06%
-37.03M
3.59%
-48.97M
-32.24%
-74.42M
-51.97%
-86.52M
-16.26%
-99.223M
-14.68%
-98.052M
1.18%
N/A
-9.25%
N/A
-6.65%
N/A
-4.44%
N/A
87.83%
N/A
666.50%
N/A
323.88%
N/A
70.09%
N/A
60.35%
Operating Margin
IMUX operating margin by date.IMUX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
IMUX eps by date.IMUX eps by date.
-1,063.20-84.00
92.10%
-52.00
38.10%
-53.20
-2.31%
N/AN/A-2.85
20.17%
-3.93
-37.89%
-3.77
4.07%
-2.11
44.03%
-1.00
52.61%
N/A
36.69%
N/A
40.80%
N/A
-23.15%
N/A
72.15%
N/A
247.62%
N/A
318.01%
N/A
88.42%
N/A
29.35%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.09
64.56%
-0.10
61.58%
-0.10
50.19%
-0.10
25.99%
-0.11
-26.64%
-0.16
-69.91%
-0.16
-63.82%
-0.15
-59.02%
-0.16
-45.45%
Revenue
Q2Q % growth
N/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-26.122M
-1.92%
-26.853M
-0.10%
-27.472M
-1.44%
-27.944M
-7.51%
-22.338M
14.49%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.13
45.83%
-0.170.0423.91%
Q2 2025
Q2Q % growth
-0.20
4.76%
-0.17-0.03-18.84%
Q1 2025
Q2Q % growth
-0.25
16.67%
-0.24-0.01-3.56%
Q4 2024
Q2Q % growth
-0.25
47.92%
-0.24-0.01-3.56%
Q3 2024
Q2Q % growth
-0.24
52.94%
-0.22-0.02-8.03%
Q2 2024
Q2Q % growth
-0.21
61.11%
-0.240.0311.76%
Q1 2024
Q2Q % growth
-0.30
48.28%
-0.27-0.03-13.12%
Q4 2023
Q2Q % growth
-0.48
70.37%
-0.520.048.31%
Q3 2023
Q2Q % growth
-0.51
26.09%
-0.560.058.68%
Q2 2023
Q2Q % growth
-0.54
25.00%
-0.53-0.01-1.03%
Q1 2023
Q2Q % growth
-0.58
21.62%
-0.53-0.05-9.67%
Q4 2022
Q2Q % growth
-1.62
-125.00%
-0.75-0.87-116.60%
Q3 2022
Q2Q % growth
-0.69
9.21%
-0.67-0.02-2.76%
Q2 2022
Q2Q % growth
-0.72
12.20%
-0.730.011.69%
Q1 2022
Q2Q % growth
-0.74
54.60%
-0.820.089.48%
Q4 2021
Q2Q % growth
-0.72
-56.52%
-0.780.067.12%
Q3 2021
Q2Q % growth
-0.76
-8.57%
-0.790.034.17%
Q2 2021
Q2Q % growth
-0.82
8.89%
-0.69-0.13-19.54%
Q1 2021
Q2Q % growth
-1.63
-106.33%
-0.69-0.94-135.50%
Q4 2020
Q2Q % growth
-0.46
17.86%
-0.610.1524.42%
Q3 2020
Q2Q % growth
-0.70
14.63%
-0.65-0.05-8.20%
Q2 2020
Q2Q % growth
-0.90
40.79%
-0.70-0.20-28.34%
Q1 2020
Q2Q % growth
-0.79
-31.27%
-0.970.1818.90%
Q4 2019
Q2Q % growth
-0.56 -0.780.2227.76%
Q3 2019
Q2Q % growth
-0.82 -0.68-0.14-19.99%
Q2 2019
Q2Q % growth
-1.52 -0.69-0.83-119.15%
IMUX Yearly EPS VS EstimatesIMUX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -200 -400 -600 -800 -1K
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
7.65K-7.65K-100.00%
IMUX Yearly Revenue VS EstimatesIMUX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS28.37% 23.48% 0% -9.58%
RevenueN/A N/A N/A N/A